{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:07:43Z","timestamp":1788865663363,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpeds.2026.115293","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:13:58Z","timestamp":1787181238000},"page":"115293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multisystem Inflammatory Syndrome Therapies in Children: A Comparative Effectiveness Trial"],"prefix":"10.1016","volume":"299","author":[{"given":"Sonia","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-5418","authenticated-orcid":false,"given":"Jocelyn Y.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2026.115293_bib2","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2026.115293_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2020.06.045","article-title":"Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York city","volume":"224","author":"Kaushik","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115293_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpeds.2021.06.002","article-title":"Multisystem inflammatory syndrome of children: subphenotypes, risk factors, biomarkers, cytokine profiles, and viral sequencing","volume":"237","author":"DeBiasi","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115293_bib5","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00431-021-03935-1","article-title":"SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment","volume":"180","author":"Abdel-Haq","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2026.115293_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2102968","article-title":"Treatment of multisystem inflammatory syndrome in children","volume":"385","author":"McArdle","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2026.115293_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12969-023-00858-z","article-title":"Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study","volume":"21","author":"Dizon","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jpeds.2026.115293_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052702","article-title":"IVIG compared with IVIG plus Infliximab in multisystem inflammatory syndrome in children","volume":"148","author":"Cole","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2026.115293_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jama.2020.10374","article-title":"Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City","volume":"324","author":"Cheung","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2026.115293_bib10","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1172\/JCI141113","article-title":"Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpeds.2026.115293_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.medj.2021.08.002","article-title":"A monocyte\/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis","volume":"2","author":"de Cevins","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.jpeds.2026.115293_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/BOR.0000000000000889","article-title":"Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children","volume":"34","author":"Cron","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jpeds.2026.115293_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101060","article-title":"Multisystem Inflammatory Syndrome therapies in children (MISTIC): a randomized trial","volume":"32","author":"Jain","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.jpeds.2026.115293_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cct.2015.11.010","article-title":"A small n sequential multiple assignment randomized trial design for use in rare disease research","volume":"46","author":"Tamura","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jpeds.2026.115293_bib15","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/sim.7900","article-title":"A Bayesian analysis of small n sequential multiple assignment randomized trials (snSMARTs)","volume":"37","author":"Wei","year":"2018","journal-title":"Stat Med"},{"key":"10.1016\/j.jpeds.2026.115293_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.105989","article-title":"Dynamic treatment regimens in small n, sequential, multiple assignment, randomized trials: an application in focal segmental glomerulosclerosis","volume":"92","author":"Chao","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jpeds.2026.115293_bib17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.4103\/sja.SJA_559_18","article-title":"The CONSORT statement","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.jpeds.2026.115293_bib18","doi-asserted-by":"crossref","first-page":"101060","DOI":"10.1016\/j.conctc.2023.101060","article-title":"Multisystem Inflammatory Syndrome Therapies in Children (MISTIC): a randomized trial","volume":"32","author":"Jain","year":"2023","journal-title":"Contemp Clin Trials Comm"},{"key":"10.1016\/j.jpeds.2026.115293_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.therap.2020.06.007","article-title":"Cinderella side effect: intravenous corticosteroid-induced bradycardia","volume":"76","author":"Coen","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.jpeds.2026.115293_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1149519","article-title":"Treatment of immunoglobulin-resistant Kawasaki disease: a Bayesian network meta-analysis of different regimens","volume":"11","author":"Pan","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jpeds.2026.115293_bib22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2147\/OPTH.S366370","article-title":"Safety of intravenous methylprednisolone in refractory and severe pediatric uveitis","volume":"16","author":"Ghoraba","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jpeds.2026.115293_bib23","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.41454","article-title":"American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2026.115293_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2352-4642(23)00020-2","article-title":"Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial","volume":"7","author":"Welzel","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpeds.2026.115293_bib25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2352-4642(23)00316-4","article-title":"Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial","volume":"8","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpeds.2026.115293_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2026.115293_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00296-021-04980-7","article-title":"Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study","volume":"42","author":"Otar Yener","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jpeds.2026.115293_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403897121","article-title":"Plasma cell-free RNA signatures of inflammatory syndromes in children","volume":"121","author":"Loy","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpeds.2026.115293_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamapediatrics.2024.5466","article-title":"Six-Month outcomes in the long-term outcomes after the multisystem inflammatory syndrome in children Study","volume":"179","author":"Truong","year":"2025","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2026.115293_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/10543406.2023.2292206","article-title":"Addressing sequential and concurrent treatment regimens in a small n sequential, multiple assignment, randomized trial (snSMART) in the MISTIC study","volume":"35","author":"Cheng","year":"2025","journal-title":"J Biopharm Stat"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626003215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347626003215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:16:53Z","timestamp":1788862613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347626003215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S0022347626003215"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115293","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multisystem Inflammatory Syndrome Therapies in Children: A Comparative Effectiveness Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2026.115293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115293"}}